Upside | ||||||
|---|---|---|---|---|---|---|
Merck & Co Inc | - | 2.42% | aa.aa | - | - | 17,089 |
| ROG | 2.37% | aa.aa | 370.50 | +0.32% | 4,058 | |
Bristol-Myers Squibb Co | - | 2.34% | aa.aa | - | - | 33,151 |
Eli Lilly and Co | - | 2.32% | aa.aa | - | - | 1,745 |
Gilead Sciences Inc | - | 2.27% | aa.aa | - | - | 12,487 |
Johnson & Johnson | - | 2.27% | aa.aa | - | - | 7,783 |
| GSK | 2.24% | aa.aa | 2,262.00 | -0.27% | 67,892 | |
Amgen Inc | - | 2.20% | aa.aa | - | - | 5,011 |
Intuitive Surgical Inc | - | 2.13% | aa.aa | - | - | 3,295 |
| NOVN | 2.12% | aa.aa | 127.92 | +0.42% | 11,100 |
TD Global Healthcare Leaders Index ETF is an exchange traded fund launched and managed by TD Asset Management, Inc. It invests in public equity markets of global region. The fund invests in stocks of companies operating across health care sectors. The fund invests in growth and value stocks of companies across diversified market capitalization. The fund seeks to track the performance of the Solactive Global Healthcare Leaders Index (CA NTR). TD Global Healthcare Leaders Index ETF was formed on April 7, 2021 and is domiciled in Canada.